Cargando…
2549. Variance Between Clinicians and Guidelines in Management of HIV/HCV Coinfection
BACKGROUND: Clinicians often encounter patients requiring simultaneous treatment for both HIV and HCV. Although several resources help clinicians identify potential drug interactions, these resources do not account for other factors that should be considered when selecting HIV and HCV regimens, such...
Autores principales: | Naggie, Susanna, Sulkowski, Mark, Schulz, Jenny, King, Edward, Schwartz, Zachary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810677/ http://dx.doi.org/10.1093/ofid/ofz360.2227 |
Ejemplares similares
-
Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007) -
Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals
por: Naggie, Susanna, et al.
Publicado: (2015) -
301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections
por: Mosquera, Diana M, et al.
Publicado: (2019) -
Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease
por: Katrak, Shereen, et al.
Publicado: (2016) -
2549 Characterizing the expression kinetics of HIV-1 envelope protein
por: Oh, Djin-Ye, et al.
Publicado: (2018)